English
Русский
English
References of the article: “A strong correlation exists between platelet consumption and platelet hyperactivation in COVID-19 patients. Pilot study of the patient cohort from CCH RAS Hospital (Troitsk).”
  1. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

    Q. Li, X. Guan, P. Wu, X. Wang, L. Zhou, Y. Tong, R. Ren, K. Leung, E. Lau, J. Wong, X. Xing, N. Xiang, Y. Wu, C. Li, Q. Chen, D. Li, T. Liu, J. Zhao, M. Liu, W. Tu, C. Chen, L. Jin, R. Yang, Q. Wang, S. Zhou, R. Wang, H. Liu, Y. Luo, Y. Liu, G. Shao, H. Li, Z. Tao, Y. Yang, Z. Deng, B. Liu, Z. Ma, Y. Zhang, G. Shi, T. Lam, J. Wu, G. Gao, B. Cowling, B. Yang, G. Leung, Z. Feng

    New England Journal of Medicine. 2020, 382, 1199-1207

    https://doi.org/10.1056/NEJMoa2001316

    Article|Google Scholar

  2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

    C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, L. Zhang, G. Fan, J. Xu, X. Gu, Z. Cheng, T. Yu, J. Xia, Y. Wei, W. Wu, X. Xie, W. Yin, H. Li, M. Liu, Y. Xiao, H. Gao, L. Guo, J. Xie, G. Wang, R. Jiang, Z. Gao, Q. Jin, J. Wang, B. Cao

    The Lancet. 2020, 395, 497-506

    https://doi.org/10.1016/S0140-6736(20)30183-5

    Article|Google Scholar

  3. Platelet gene expression and function in patients with COVID-19

    B. Manne, F. Denorme, E. Middleton, I. Portier, J. Rowley, C. Stubben, A. Petrey, N. Tolley, L. Guo, M. Cody, A. Weyrich, C. Yost, M. Rondina, R. Campbell

    Blood. 2020, 136, 1317-1329

    https://doi.org/10.1182/blood.2020007214

    Article|Google Scholar

  4. Thrombocytopenia and its association with mortality in patients with COVID‐19

    X. Yang, Q. Yang, Y. Wang, Y. Wu, J. Xu, Y. Yu, Y. Shang

    Journal of Thrombosis and Haemostasis. 2020, 18, 1469-1472

    https://doi.org/10.1111/jth.14848

    Article|Google Scholar

  5. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

    G. Lippi, M. Plebani, B. Henry

    Clinica Chimica Acta. 2020, 506, 145-148

    https://doi.org/10.1016/j.cca.2020.03.022

    Article|Google Scholar

  6. Platelets in COVID-19: “innocent by-standers” or active participants?

    O. An, A. Martyanov, M. Stepanyan, A. Boldova, S. Rumyantsev, M. Panteleev, F. Ataullakhanov, A. Rumyantsev, A. Sveshnikova

    Pediatric Hematology/Oncology and Immunopathology. , 20, 184-191

    https://doi.org/10.24287/1726-1708-2021-20-1-184-191

    Article|Google Scholar

  7. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

    Q. Ye, B. Wang, J. Mao

    Journal of Infection. 2020, 80, 607-613

    https://doi.org/10.1016/j.jinf.2020.03.037

    Article|Google Scholar

  8. Hematological findings and complications of COVID ‐19

    E. Terpos, I. Ntanasis‐Stathopoulos, I. Elalamy, E. Kastritis, T. Sergentanis, M. Politou, T. Psaltopoulou, G. Gerotziafas, M. Dimopoulos

    American Journal of Hematology. 2020, 95, 834-847

    https://doi.org/10.1002/ajh.25829

    Article|Google Scholar

  9. Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis

    M. Panigada, N. Bottino, P. Tagliabue, G. Grasselli, C. Novembrino, V. Chantarangkul, A. Pesenti, F. Peyvandi, A. Tripodi

    Journal of Thrombosis and Haemostasis. 2020, 18, 1738-1742

    https://doi.org/10.1111/jth.14850

    Article|Google Scholar

  10. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

    N. Tang, H. Bai, X. Chen, J. Gong, D. Li, Z. Sun

    Journal of Thrombosis and Haemostasis. 2020, 18, 1094-1099

    https://doi.org/10.1111/jth.14817

    Article|Google Scholar

  11. Incidence of thrombotic complications in critically ill ICU patients with COVID-19

    F. Klok, M. Kruip, N. van der Meer, M. Arbous, D. Gommers, K. Kant, F. Kaptein, J. van Paassen, M. Stals, M. Huisman, H. Endeman

    Thrombosis Research. 2020, 191, 145-147

    https://doi.org/10.1016/j.thromres.2020.04.013

    Article|Google Scholar

  12. The trinity of COVID-19: immunity, inflammation and intervention

    M. Tay, C. Poh, L. Rénia, P. MacAry, L. Ng

    Nature Reviews Immunology. 2020, 20, 363-374

    https://doi.org/10.1038/s41577-020-0311-8

    Article|Google Scholar

  13. Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19

    R. Alon, M. Sportiello, S. Kozlovski, A. Kumar, E. Reilly, A. Zarbock, N. Garbi, D. Topham

    Nature Reviews Immunology. 2021, 21, 49-64

    https://doi.org/10.1038/s41577-020-00470-2

    Article|Google Scholar

  14. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

    A. Bonaventura, A. Vecchié, L. Dagna, K. Martinod, D. Dixon, B. Van Tassell, F. Dentali, F. Montecucco, S. Massberg, M. Levi, A. Abbate

    Nature Reviews Immunology. 2021, 21, 319-329

    https://doi.org/10.1038/s41577-021-00536-9

    Article|Google Scholar

  15. Tissue factor as a link between inflammation and coagulation

    M. Witkowski, U. Landmesser, U. Rauch

    Trends in Cardiovascular Medicine. 2016, 26, 297-303

    https://doi.org/10.1016/j.tcm.2015.12.001

    Article|Google Scholar

  16. von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke

    F. Denorme, K. Vanhoorelbeke, S. De Meyer

    Frontiers in Immunology. , 10, 2884

    https://doi.org/10.3389/fimmu.2019.02884

    Article|Google Scholar

  17. Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

    J. Hirsh, T. Warkentin, S. Shaughnessy, S. Anand, J. Halperin, R. Raschke, C. Granger, E. Ohman, J. Dalen

    Chest. 2001, 119, 64S-94S

    https://doi.org/10.1378/chest.119.1_suppl.64S

    Article|Google Scholar

  18. COVID-19 and its implications for thrombosis and anticoagulation

    J. Connors, J. Levy

    Blood. 2020, 135, 2033-2040

    https://doi.org/10.1182/blood.2020006000

    Article|Google Scholar

  19. Higher heparin dosages reduce thromboembolic complications in patients with COVID-19 pneumonia

    C. Carallo, F. Pugliese, E. Vettorato, C. Tripolino, L. Delle Donne, G. Guarrera, W. Spagnolli, S. Cozzio

    Journal of Investigative Medicine. 2021, 69, 884-887

    https://doi.org/10.1136/jim-2020-001628

    Article|Google Scholar

  20. Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis

    J. Gratz, M. Wiegele, M. Maleczek, H. Herkner, H. Schöchl, E. Chwala, P. Knöbl, E. Schaden

    Frontiers in Medicine. 2021, 8,

    https://doi.org/10.3389/fmed.2021.647917

    Article|Google Scholar

  21. Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?

    V. Bianconi, F. Violi, F. Fallarino, P. Pignatelli, A. Sahebkar, M. Pirro

    Drugs. 2020, 80, 1383-1396

    https://doi.org/10.1007/s40265-020-01365-1

    Article|Google Scholar

  22. Systems biology insights into the meaning of the platelet's dual-receptor thrombin signaling

    A. Sveshnikova, A. Balatskiy, A. Demianova, T. Shepelyuk, S. Shakhidzhanov, M. Balatskaya, A. Pichugin, F. Ataullakhanov, M. Panteleev

    Journal of Thrombosis and Haemostasis. 2016, 14, 2045-2057

    https://doi.org/10.1111/jth.13442

    Article|Google Scholar

  23. Coagulation factors bound to procoagulant platelets concentrate in cap structures to promote clotting

    N. Podoplelova, A. Sveshnikova, Y. Kotova, A. Eckly, N. Receveur, D. Nechipurenko, S. Obydennyi, I. Kireev, C. Gachet, F. Ataullakhanov, P. Mangin, M. Panteleev

    Blood. 2016, 128, 1745-1755

    https://doi.org/10.1182/blood-2016-02-696898

    Article|Google Scholar

  24. Flow cytometry for pediatric platelets

    A. Ignatova, E. Ponomarenko, D. Polokhov, E. Suntsova, P. Zharkov, D. Fedorova, E. Balashova, A. Rudneva, V. Ptushkin, E. Nikitin, A. Shcherbina, A. Maschan, G. Novichkova, M. Panteleev

    Platelets. 2019, 30, 428-437

    https://doi.org/10.1080/09537104.2018.1513473

    Article|Google Scholar

  25. New Fundamentals in Hemostasis

    H. Versteeg, J. Heemskerk, M. Levi, P. Reitsma

    Physiological Reviews. 2013, 93, 327-358

    https://doi.org/10.1152/physrev.00016.2011

    Article|Google Scholar

  26. Clot Contraction Drives the Translocation of Procoagulant Platelets to Thrombus Surface

    D. Nechipurenko, N. Receveur, A. Yakimenko, T. Shepelyuk, A. Yakusheva, R. Kerimov, S. Obydennyy, A. Eckly, C. Léon, C. Gachet, E. Grishchuk, F. Ataullakhanov, P. Mangin, M. Panteleev

    Arteriosclerosis, Thrombosis, and Vascular Biology. 2019, 39, 37-47

    https://doi.org/10.1161/ATVBAHA.118.311390

    Article|Google Scholar

  27. Platelet Apoptosis and Apoptotic Platelet Clearance by Macrophages in Secondary Dengue Virus Infections

    M. Alonzo, T. Lacuesta, E. Dimaano, T. Kurosu, L. Suarez, C. Mapua, Y. Akeda, R. Matias, D. Kuter, S. Nagata, F. Natividad, K. Oishi

    The Journal of Infectious Diseases. 2012, 205, 1321-1329

    https://doi.org/10.1093/infdis/jis180

    Article|Google Scholar

  28. The Impact of COVID-19 Disease on Platelets and Coagulation

    G. Wool, J. Miller

    Pathobiology. 2021, 88, 15-27

    https://doi.org/10.1159/000512007

    Article|Google Scholar

  29. Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19

    Y. Zaid, F. Puhm, I. Allaeys, A. Naya, M. Oudghiri, L. Khalki, Y. Limami, N. Zaid, K. Sadki, R. Ben El Haj, W. Mahir, L. Belayachi, B. Belefquih, A. Benouda, A. Cheikh, M. Langlois, Y. Cherrah, L. Flamand, F. Guessous, E. Boilard

    Circulation Research. 2020, 127, 1404-1418

    https://doi.org/10.1161/CIRCRESAHA.120.317703

    Article|Google Scholar

  30. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways

    J. Burkhart, M. Vaudel, S. Gambaryan, S. Radau, U. Walter, L. Martens, J. Geiger, A. Sickmann, R. Zahedi

    Blood. 2012, 120, e73-e82

    https://doi.org/10.1182/blood-2012-04-416594

    Article|Google Scholar

  31. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19

    S. Zhang, Y. Liu, X. Wang, L. Yang, H. Li, Y. Wang, M. Liu, X. Zhao, Y. Xie, Y. Yang, S. Zhang, Z. Fan, J. Dong, Z. Yuan, Z. Ding, Y. Zhang, L. Hu

    Journal of Hematology & Oncology. 2020, 13,

    https://doi.org/10.1186/s13045-020-00954-7

    Article|Google Scholar

  32. Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia

    F. Taus, G. Salvagno, S. Canè, C. Fava, F. Mazzaferri, E. Carrara, V. Petrova, R. Barouni, F. Dima, A. Dalbeni, S. Romano, G. Poli, M. Benati, S. De Nitto, G. Mansueto, M. Iezzi, E. Tacconelli, G. Lippi, V. Bronte, P. Minuz

    Arteriosclerosis, Thrombosis, and Vascular Biology. 2020, 40, 2975-2989

    https://doi.org/10.1161/ATVBAHA.120.315175

    Article|Google Scholar

  33. Cellular automata as models of complexity

    S. Wolfram

    Nature. 1984, 311, 419-424

    https://doi.org/10.1038/311419a0

    Article|Google Scholar

  34. The biogenesis of platelets from megakaryocyte proplatelets

    S. Patel

    Journal of Clinical Investigation. 2005, 115, 3348-3354

    https://doi.org/10.1172/JCI26891

    Article|Google Scholar

  35. Thrombopoietin levels in patients with disorders of platelet production: Diagnostic potential and utility in predicting response to TPO Receptor agonists

    R. Makar, O. Zhukov, M. Sahud, D. Kuter

    American Journal of Hematology. 2013, 88, 1041-1044

    https://doi.org/10.1002/ajh.23562

    Article|Google Scholar

  36. Platelet clearance by the hepatic Ashwell-Morrell receptor: mechanisms and biological significance

    K. Hoffmeister, H. Falet

    Thrombosis Research. 2016, 141, S68-S72

    https://doi.org/10.1016/S0049-3848(16)30370-X

    Article|Google Scholar

  37. Platelet reticulated forms, size indexes, and functional activity. Interactions in healthy volunteers

    V. V. Bodrova, O. N. Shustova, S. G. Khaspekova, and A. V. Mazurov

    Platelets. 2021, , 1-6

    https://doi.org/10.1080/09537104.2021.1922659

    Article|Google Scholar

  38. Ultrastructural, transcriptional, and functional differences between human reticulated and non‐reticulated platelets

    L. Hille, M. Lenz, A. Vlachos, B. Grüning, L. Hein, F. Neumann, T. Nührenberg, D. Trenk

    Journal of Thrombosis and Haemostasis. 2020, 18, 2034-2046

    https://doi.org/10.1111/jth.14895

    Article|Google Scholar

  39. Investigation of the efficacy and safety of eltrombopag to correct thrombocytopenia in moderate to severe dengue patients - a phase II randomized controlled clinical trial

    S. Chakraborty, S. Alam, M. Sayem, M. Sanyal, T. Das, P. Saha, M. Sayem, B. Byapari, C. Tabassum, A. Kabir, M. Amin, A. Nabi

    EClinicalMedicine. 2020, 29-30, 100624

    https://doi.org/10.1016/j.eclinm.2020.100624

    Article|Google Scholar

  40. Mean Platelet Volume and Immature Platelet Fraction in Autoimmune Disorders

    D. Schmoeller, M. Picarelli, T. Paz Munhoz, C. Poli de Figueiredo, H. Staub

    Frontiers in Medicine. 2017, 4,

    https://doi.org/10.3389/fmed.2017.00146

    Article|Google Scholar

  41. Characteristics of platelet count and size and diagnostic accuracy of mean platelet volume in patients with venous thromboembolism. A systematic review and meta-analysis

    S. Kovács, Z. Csiki, K. Zsóri, Z. Bereczky, A. Shemirani

    Platelets. 2019, 30, 139-147

    https://doi.org/10.1080/09537104.2017.1414175

    Article|Google Scholar

  42. Anatomical and Pathological Observation and Analysis of SARS and COVID-19: Microthrombosis Is the Main Cause of Death

    W. Chen, J. Pan

    Biological Procedures Online. 2021, 23,

    https://doi.org/10.1186/s12575-021-00142-y

    Article|Google Scholar

  43. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2

    S. Yin, M. Huang, D. Li, N. Tang

    Journal of Thrombosis and Thrombolysis. 2021, 51, 1107-1110

    https://doi.org/10.1007/s11239-020-02105-8

    Article|Google Scholar

  44. The value of the platelet count and platelet indices in differentiation of COVID‐19 and influenza pneumonia

    N. Ozcelik, S. Ozyurt, B. Yilmaz Kara, A. Gumus, U. Sahin

    Journal of Medical Virology. 2021, 93, 2221-2226

    https://doi.org/10.1002/jmv.26645

    Article|Google Scholar

  45. Severe thrombocytopenia as a complication of acute Epstein-Barr virus infection

    R. Likic, D. Kuzmanic

    Wiener Klinische Wochenschrift. 2004, 116, 47-50

    https://doi.org/10.1007/BF03040424

    Article|Google Scholar

  46. Measurement of phosphatidylserine exposure during storage of platelet concentrates using the novel probe lactadherin: a comparison study with annexin V

    A. Albanyan, M. Murphy, J. Rasmussen, C. Heegaard, P. Harrison

    Transfusion. 2009, 49, 99-107

    https://doi.org/10.1111/j.1537-2995.2008.01933.x

    Article|Google Scholar

  47. Procoagulant Platelets: Mechanisms of Generation and Action

    N. Podoplelova, D. Nechipurenko, A. Ignatova, A. Sveshnikova, M. Panteleev

    Hämostaseologie. 2021, 41, 146-153

    https://doi.org/10.1055/a-1401-2706

    Article|Google Scholar

  48. Collagen But Not Fibrinogen Surfaces Induce Bleb Formation, Exposure of Phosphatidylserine, and Procoagulant Activity of Adherent Platelets: Evidence for Regulation by Protein Tyrosine Kinase-Dependent Ca2+ Responses

    J. Heemskerk, W. Vuist, M. Feijge, C. Reutelingsperger, T. Lindhout

    Blood. 1997, 90, 2615-2625

    https://doi.org/10.1182/blood.V90.7.2615

    Article|Google Scholar

  49. Coated-Platelets Improve Prediction of Stroke and Transient Ischemic Attack in Asymptomatic Internal Carotid Artery Stenosis

    A. Kirkpatrick, A. Tafur, A. Vincent, G. Dale, C. Prodan

    Stroke. 2014, 45, 2995-3001

    https://doi.org/10.1161/STROKEAHA.114.006492

    Article|Google Scholar

  50. Inflammation, endothelium, and coagulation in sepsis

    M. Schouten, W. Wiersinga, M. Levi, T. van der Poll

    Journal of Leukocyte Biology. 2008, 83, 536-545

    https://doi.org/10.1189/jlb.0607373

    Article|Google Scholar

  51. The lung microvascular endothelium as a therapeutic target in severe influenza

    S. Armstrong, S. Mubareka, W. Lee

    Antiviral Research. 2013, 99, 113-118

    https://doi.org/10.1016/j.antiviral.2013.05.003

    Article|Google Scholar

  52. Thrombocytopenia and its association with mortality in patients with COVID‐19

    X. Yang, Q. Yang, Y. Wang, Y. Wu, J. Xu, Y. Yu, Y. Shang

    Journal of Thrombosis and Haemostasis. 2020, 18, 1469-1472

    https://doi.org/10.1111/jth.14848

    Article|Google Scholar

  53. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19

    J. Thachil, N. Tang, S. Gando, A. Falanga, M. Cattaneo, M. Levi, C. Clark, T. Iba

    Journal of Thrombosis and Haemostasis. 2020, 18, 1023-1026

    https://doi.org/10.1111/jth.14810

    Article|Google Scholar

  54. Temporal Aspects of Heparin-Induced Thrombocytopenia

    T. Warkentin, J. Kelton

    New England Journal of Medicine. 2001, 344, 1286-1292

    https://doi.org/10.1056/NEJM200104263441704

    Article|Google Scholar

  55. Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin

    T. Warkentin, M. Levine, J. Hirsh, P. Horsewood, R. Roberts, M. Gent, J. Kelton

    New England Journal of Medicine. 1995, 332, 1330-1336

    https://doi.org/10.1056/NEJM199505183322003

    Article|Google Scholar

  56. Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis

    C. S. Kow and S. S. Hasan

    Journal of Thrombosis and Thrombolysis. 2021, ,

    https://doi.org/10.1007/s11239-021-02436-0

    Article|Google Scholar

  57. Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

    J. Chan, Y. Yao, M. Yeung, W. Deng, L. Bao, L. Jia, F. Li, C. Xiao, H. Gao, P. Yu, J. Cai, H. Chu, J. Zhou, H. Chen, C. Qin, K. Yuen

    Journal of Infectious Diseases. 2015, 212, 1904-1913

    https://doi.org/10.1093/infdis/jiv392

    Article|Google Scholar

  58. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

    I. Hung, K. Lung, E. Tso, R. Liu, T. Chung, M. Chu, Y. Ng, J. Lo, J. Chan, A. Tam, H. Shum, V. Chan, A. Wu, K. Sin, W. Leung, W. Law, D. Lung, S. Sin, P. Yeung, C. Yip, R. Zhang, A. Fung, E. Yan, K. Leung, J. Ip, A. Chu, W. Chan, A. Ng, R. Lee, K. Fung, A. Yeung, T. Wu, J. Chan, W. Yan, W. Chan, J. Chan, A. Lie, O. Tsang, V. Cheng, T. Que, C. Lau, K. Chan, K. To, K. Yuen

    The Lancet. 2020, 395, 1695-1704

    https://doi.org/10.1016/S0140-6736(20)31042-4

    Article|Google Scholar

  59. Small procoagulant platelets in diabetes type 2

    M. Edvardsson, M. Oweling, P. Järemo

    Thrombosis Research. 2020, 195, 1-7

    https://doi.org/10.1016/j.thromres.2020.06.033

    Article|Google Scholar

  60. Coagulation testing and management in liver disease patients

    M. Stotts, J. Davis, N. Shah

    Current Opinion in Gastroenterology. 2020, 36, 169-176

    https://doi.org/10.1097/MOG.0000000000000635

    Article|Google Scholar

  61. Platelet and coagulation disorders in newly diagnosed patients with pulmonary arterial hypertension

    E. Vrigkou, I. Tsangaris, S. Bonovas, P. Kopterides, E. Kyriakou, D. Konstantonis, A. Pappas, A. Anthi, A. Gialeraki, S. Orfanos, A. Armaganidis, A. Tsantes

    Platelets. 2019, 30, 646-651

    https://doi.org/10.1080/09537104.2018.1499890

    Article|Google Scholar

  62. Levels of procoagulant microvesicles are elevated after traumatic injury and platelet microvesicles are negatively correlated with mortality

    N. Curry, A. Raja, J. Beavis, S. Stanworth, P. Harrison

    Journal of Extracellular Vesicles. 2014, 3, 25625

    https://doi.org/10.3402/jev.v3.25625

    Article|Google Scholar